Nasdaq - Delayed Quote
USD
Fidelity Select Pharmaceuticals Port (FPHAX)
37.58
+1.14
(+3.13%)
At close: 8:10:03 PM EDT
Top 10 Holdings (72.07% of Total Assets)
Sector Weightings
Sector
FPHAX
Healthcare
100.00%
Real Estate
0.00%
Consumer Cyclical
0.00%
Basic Materials
0.00%
Consumer Defensive
0.00%
Technology
0.00%
Communication Services
0.00%
Financial Services
0.00%
Utilities
0.00%
Industrials
0.00%
Energy
0.00%
Overall Portfolio Composition (%)
| Cash | 1.05% |
| Stocks | 98.44% |
|---|---|
| Bonds | 0.08% |
| Others | 0.43% |
| Preferred | 0.00% |
| Convertible | 0.00% |
Bond Ratings
| US Government | 0.00% |
| AAA | -- |
|---|---|
| AA | -- |
| A | -- |
| BBB | -- |
| BB | -- |
| B | -- |
| Below B | -- |
| Other | -- |
Equity Holdings
| Average | FPHAX | Category Average |
|---|---|---|
|
Price/Earnings
|
0.04 | 24.55 |
|
Price/Book
|
0.21 | 5.28 |
|
Price/Sales
|
0.23 | 2.06 |
|
Price/Cashflow
|
0.06 | 17.54 |
|
Median Market Cap
|
118,187.81 | 34,862.81 |
|
3 Year Earnings Growth
|
28.09 | 32.48 |
Bond Holdings
| Average | FPHAX | Category Average |
|---|---|---|
|
Maturity
|
-- | -- |
|
Duration
|
6 | -- |
|
Credit Quality
|
-- | -- |
Performance & Risk
| YTD Return | 20.44% |
| 5y Average Return | 14.64% |
| Rank in Category (ytd) | 44 |
| % Rank in Category (ytd) | -- |
| Beta (5Y Monthly) | 0.71 |
| Morningstar Risk Rating |
Fund Overview
| Category | Health |
| Fund Family | Fidelity Investments |
| Net Assets | 1.61B |
| YTD Return | 13.94% |
| Yield | 2.55% |
| Morningstar Rating | |
| Inception Date | Jun 18, 2001 |
Fund Summary
The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
